Business Description
CanSino Biologics Inc
ISIN : CNE100003F01
Share Class Description:
HKSE:06185: Class HCompare
Compare
Traded in other countries / regions
06185.Hong Kong688185.ChinaCASBF.USACJH.Germany IPO Date
2019-03-28Description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.9 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | -1.12 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 0.53 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 152.5 | |||||
3-Year EBITDA Growth Rate | -57.3 | |||||
3-Year EPS without NRI Growth Rate | -44.6 | |||||
3-Year FCF Growth Rate | -21.2 | |||||
3-Year Book Growth Rate | -7.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 67.24 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.02 | |||||
9-Day RSI | 30.27 | |||||
14-Day RSI | 35.03 | |||||
6-1 Month Momentum % | 2.32 | |||||
12-1 Month Momentum % | -22.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.39 | |||||
Quick Ratio | 2.22 | |||||
Cash Ratio | 1.91 | |||||
Days Inventory | 117.82 | |||||
Days Sales Outstanding | 704.82 | |||||
Days Payable | 36.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 3.5 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -241.82 | |||||
Operating Margin % | -561.68 | |||||
Net Margin % | -424.99 | |||||
FCF Margin % | -178.43 | |||||
ROE % | -27.55 | |||||
ROA % | -16.25 | |||||
ROIC % | -35.81 | |||||
ROC (Joel Greenblatt) % | -66.26 | |||||
ROCE % | -27.52 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.74 | |||||
PB Ratio | 0.76 | |||||
Price-to-Tangible-Book | 0.79 | |||||
EV-to-EBIT | -2.36 | |||||
EV-to-EBITDA | -2.36 | |||||
EV-to-Revenue | 12.47 | |||||
EV-to-FCF | -6.9 | |||||
Price-to-Net-Current-Asset-Value | 2.47 | |||||
Price-to-Net-Cash | 6.97 | |||||
Earnings Yield (Greenblatt) % | -42.37 | |||||
FCF Yield % | -9.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CanSino Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 388.458 | ||
EPS (TTM) (HK$) | -6.687 | ||
Beta | 0.46 | ||
Volatility % | 50.87 | ||
14-Day RSI | 35.03 | ||
14-Day ATR (HK$) | 0.933018 | ||
20-Day SMA (HK$) | 18.663 | ||
12-1 Month Momentum % | -22.76 | ||
52-Week Range (HK$) | 14.8 - 29.15 | ||
Shares Outstanding (Mil) | 247.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CanSino Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CanSino Biologics Inc Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
CanSino Biologics Inc Frequently Asked Questions
What is CanSino Biologics Inc(HKSE:06185)'s stock price today?
The current price of HKSE:06185 is HK$16.94. The 52 week high of HKSE:06185 is HK$29.15 and 52 week low is HK$14.80.
When is next earnings date of CanSino Biologics Inc(HKSE:06185)?
The next earnings date of CanSino Biologics Inc(HKSE:06185) is 2024-08-30 Est..
Does CanSino Biologics Inc(HKSE:06185) pay dividends? If so, how much?
CanSino Biologics Inc(HKSE:06185) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |